SHIELD Lab
@bgauthierlab
Strategic Healing and Immuno-Endocrine Division led by BGauthier at @cabimer @FProgresoysalud. With @BreakthroughT1D, @diabetes_CERO @ciberdem
ID: 1854920871988576256
https://www.cabimer.es/en/research-groups/pancreatic-islet-development-regeneration/ 08-11-2024 16:16:46
62 Tweet
71 Followers
419 Following
Join us in San Francisco at #ENDO2025 for cutting edge world class endocrinology! Endocrine Society
CellMarker 2.0 An updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data http://117.50.127.228/CellMarker/index.html A nice resource for cell type markers for supervised clustering😁 Nucleic Acids Res 2023 academic.oup.com/nar/article/51…
Ayúdanos con este nuevo proyecto de investigación! Estamos reclutando de nuevo. Anímate! Cabimer AXA Research Fund Universidad de Sevilla
La Fundación Fundación DiabetesCERO lanza la convocatoria internacional 'Frontiers in T1D Cure 2025', una iniciativa para impulsar proyectos de #diabetes tipo 1. Se otorgarán dos ayudas de 100.000 € a investigadores consolidados con enfoque traslacional lc.cx/7gr0EV
🌟 Passionate about immunology & diabetes research? Want to do a PhD in Seville, Spain? ☀️🧬 Join our lab at CABIMER to study immune–islet crosstalk & α→β cell transdifferentiation in Type 1 Diabetes 🩺 📩 Apply by email: [email protected]
🏆Honored to coordinate a new Breakthrough T1D project with @DiabetesCERO, Life Length, Hospital Virgen Macarena, Biobanco del SSPA, Hospital Puerta de Hierro. 📍From Cabimer, @FPSalud & Junta de Andalucía, advancing early T1D detection and telomere research. ✨ share.google/hNUfUfy7jGAvzU…
Great pleasure to host Joaquin Dopazo from Fundación Progreso y Salud at Cabimer last Friday! 🚀 An inspiring talk on how AI is reshaping targeted drug discovery. #AI #DrugDiscovery #Innovation Are we obsolete?? Don't think so but 😬
📰 La Vanguardia destaca el trabajo del grupo de Benoit Gauthier en CABIMER, que desarrolla una molécula capaz de proteger y regenerar células beta, abriendo nuevas vías terapéuticas contra la diabetes tipo 1. Más info: lnkd.in/dWVBtHeE #CABIMER #Investigación #Diabetes